Sanofi India Limited (IN:SANOFI)
:SANOFI
Want to see IN:SANOFI full AI Analyst Report?
SANOFI Stock Chart & Stats
₹4142.75
₹54.40(0.91%)
At close: 4:00 PM EST
₹4142.75
₹54.40(0.91%)
Day’s Range― - ―
52-Week Range₹3,057.60 - ₹6,399.95
Previous CloseN/A
Volume15.46K
Average Volume (3M)3.77K
Market Cap
₹73.15B
Enterprise Value₹68.76B
Total Cash (Recent Filing)₹3.13B
Total Debt (Recent Filing)₹209.00M
Price to Earnings (P/E)23.6
Beta0.71
Next Earnings
Jul 28, 2026EPS Estimate
44.4Next Dividend Ex-DateN/A
Dividend Yield4.73%
Share Statistics
EPS (TTM)146.55
Shares Outstanding23,030,000
10 Day Avg. Volume3,778
30 Day Avg. Volume3,766
Financial Highlights & Ratios
PEG Ratio6.96
Price to Book (P/B)12.56
Price to Sales (P/S)5.12
P/FCF Ratio22.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)168.05
Revenue Forecast (FY)₹19.50B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage gives Sanofi India durable financial flexibility to absorb industry shocks, fund working capital, support sustained dividends or buybacks and fund targeted investments without stressing liquidity. This conservatism reduces refinancing risk over the next 2–6 months and beyond.
Strong Free Cash FlowHigh, consistent free cash flow that tracks earnings strengthens the company’s ability to self-fund operations, capital expenditures and distributions. Robust 2025 FCF growth enhances liquidity buffers and provides durable support for strategic investments or shareholder returns despite revenue variability.
High Operating Profitability And ROESustained double-digit EBIT margins and very strong ROE indicate an efficient operating model and profitable product mix. This structural profitability supports long-term cash generation and competitive reinvestment capacity, helping maintain margins and fund growth initiatives over time.
Bears Say
Revenue Decline And Choppy GrowthA weakening top-line trend reduces scale benefits and constrains long-term reinvestment capacity. Persistent or recurring revenue declines can pressure field-force productivity, limit pricing power, and force trade‑offs between margin protection and volume growth, impairing the company’s structural growth runway.
Gross Margin CompressionA large structural fall in gross margin erodes the firm’s earnings buffer and makes margins more sensitive to fixed costs and market pricing. If driven by mix shifts or cost pressures, sustained compression will reduce sustainable free cash flow and limit ability to fund R&D, marketing, or maintain payouts.
Volatile Operating Cash FlowIrregular cash conversion increases uncertainty about the reliability of reported earnings and limits predictable funding for operations or dividends. Volatility driven by working capital swings can strain short-term liquidity and complicate planning for investments or managing supply agreements over the medium term.
Sanofi India Limited News
SANOFI FAQ
What was Sanofi India Limited’s price range in the past 12 months?
Sanofi India Limited lowest stock price was ₹3057.60 and its highest was ₹6399.95 in the past 12 months.
What is Sanofi India Limited’s market cap?
Sanofi India Limited’s market cap is ₹73.15B.
When is Sanofi India Limited’s upcoming earnings report date?
Sanofi India Limited’s upcoming earnings report date is Jul 28, 2026 which is in 46 days.
How were Sanofi India Limited’s earnings last quarter?
Sanofi India Limited released its earnings results on Apr 28, 2026. The company reported ₹44.5 earnings per share for the quarter, missing the consensus estimate of ₹44.6 by -₹0.1.
Is Sanofi India Limited overvalued?
According to Wall Street analysts Sanofi India Limited’s price is currently Overvalued.
Does Sanofi India Limited pay dividends?
Sanofi India Limited pays a Semiannually dividend of ₹48 which represents an annual dividend yield of 4.73%. See more information on Sanofi India Limited dividends here
What is Sanofi India Limited’s EPS estimate?
Sanofi India Limited’s EPS estimate is 44.4.
How many shares outstanding does Sanofi India Limited have?
Sanofi India Limited has 23,030,000 shares outstanding.
What happened to Sanofi India Limited’s price movement after its last earnings report?
Sanofi India Limited reported an EPS of ₹44.5 in its last earnings report, missing expectations of ₹44.6. Following the earnings report the stock price went up 1.047%.
Which hedge fund is a major shareholder of Sanofi India Limited?
Currently, no hedge funds are holding shares in IN:SANOFI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sanofi India Limited
Sanofi India Limited is a pharmaceutical firm engaged in the production and distribution of medicinal products across India, Singapore, and international markets. Its extensive product portfolio covers a wide range of therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, anti-infectives, epilepsy, and allergies. The company also offers essential vitamins, antihistamines, minerals, and other supplements, marketed under well-known brands such as Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil, reaching consumers through a network of independent distributors. Beyond its domestic and regional sales, Sanofi India Limited also exports its pharmaceutical offerings. Established in 1956, the company was initially known as Aventis Pharma Limited before adopting its current name, Sanofi India Limited, in May 2012. It is headquartered in Mumbai, India, and functions as a subsidiary of Hoechst GmbH.
Technical Analysis
Abbott India Limited
―
Cipla Ltd
―
Gland Pharma Ltd.
―
GlaxoSmithKline Pharmaceuticals Limited
―
PFIZER LIMITED
―